October 7, 2021 -- Twist Bioscience and Centogene have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.
The kits will be designed to make genetic testing more accessible to patients and add to the understanding of rare diseases. Their collaboration aims to augment the bio databank on rare diseases and may contribute to the discovery and development of new therapies to treat these diseases in the future, the companies said.